OncoSil Medical Limited (ASX:OSL)
Australia
· Delayed Price · Currency is AUD 0.618
-0.007 (-1.20%)
At close: Mar 9, 2026
OncoSil Medical Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -12.92 | -15.1 | -11.91 | -11.34 | -10.73 | -10.43 | Upgrade
|
| Depreciation & Amortization | 0.05 | 0.04 | 0.04 | 0.18 | 0.19 | 0.18 | Upgrade
|
| Stock-Based Compensation | 0.67 | 0.67 | 0.62 | 0.39 | 0.59 | -0.14 | Upgrade
|
| Other Operating Activities | -2.99 | 0.05 | -0.07 | -0 | 0.09 | 0.11 | Upgrade
|
| Change in Accounts Receivable | 0.04 | 0.04 | 0.05 | -0.38 | 0.27 | -0.03 | Upgrade
|
| Change in Accounts Payable | 2.03 | 2.03 | 0.47 | -0.08 | -0.07 | -0.05 | Upgrade
|
| Change in Other Net Operating Assets | 0.21 | 0.21 | -0.01 | -0.08 | -0.46 | 1.54 | Upgrade
|
| Operating Cash Flow | -12.91 | -12.06 | -10.82 | -11.32 | -10.11 | -8.82 | Upgrade
|
| Capital Expenditures | -0.01 | -0.01 | -0.2 | -0.06 | -0.01 | -0.05 | Upgrade
|
| Investing Cash Flow | -0.01 | -0.01 | -0.2 | -0.06 | -0.01 | -0.05 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.03 | Upgrade
|
| Long-Term Debt Repaid | - | -0.05 | -0.06 | -0.19 | -0.16 | -0.12 | Upgrade
|
| Total Debt Repaid | -0.06 | -0.05 | -0.06 | -0.19 | -0.16 | -0.15 | Upgrade
|
| Net Debt Issued (Repaid) | -0.06 | -0.05 | -0.06 | -0.19 | -0.16 | -0.15 | Upgrade
|
| Issuance of Common Stock | 4.11 | 6.33 | 3.59 | 6.97 | 9.32 | 0.26 | Upgrade
|
| Other Financing Activities | 3.3 | 6.45 | 2.6 | 2.71 | - | - | Upgrade
|
| Financing Cash Flow | 7.35 | 12.73 | 6.13 | 9.49 | 9.16 | 0.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.05 | -0.04 | - | - | - | - | Upgrade
|
| Net Cash Flow | -5.61 | 0.61 | -4.89 | -1.89 | -0.96 | -8.76 | Upgrade
|
| Free Cash Flow | -12.91 | -12.08 | -11.02 | -11.37 | -10.12 | -8.87 | Upgrade
|
| Free Cash Flow Margin | -346.72% | -786.66% | -704.07% | -775.06% | -951.30% | -683.14% | Upgrade
|
| Free Cash Flow Per Share | -0.85 | -1.10 | -2.00 | -4.03 | -4.99 | -4.34 | Upgrade
|
| Cash Interest Paid | 0.02 | 0 | 0 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Cash Income Tax Paid | - | -1.05 | -1.1 | -0.82 | -0.83 | -2.76 | Upgrade
|
| Levered Free Cash Flow | -8.53 | -6.46 | -6.53 | -7.14 | -6.3 | -5.14 | Upgrade
|
| Unlevered Free Cash Flow | -8.51 | -6.46 | -6.53 | -7.14 | -6.28 | -5.13 | Upgrade
|
| Change in Working Capital | 2.28 | 2.28 | 0.5 | -0.53 | -0.26 | 1.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.